Literature DB >> 6165656

Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.

P J Jenkins, W M Melia, B Portmann, J M Longworth Krafft, R Williams.   

Abstract

The occurrence of hepatocellular carcinoma in HBsAg-negative chronic active hepatitis is described in two patients. signs of the tumour appeared 18 years and nine years after the first clinical signs of chronic active hepatitis, although in one patients analysis of stored sera showed the serum alpha-fetoprotein levels had been rising over the previous 33 months. Female preponderance in HBsAg-negative chronic active hepatitis may partly account for the rarity of this complication, and the occurrence of hepatocellular carcinoma may also be a reflection of the better survival now being obtained in HBsAg-negative chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165656      PMCID: PMC1419148          DOI: 10.1136/gut.22.4.332

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Cirrhosis and hepatoma occurring at Boston City Hospital (1917-1968).

Authors:  D T Purtilo; L S Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

2.  Familial active chronic hepatitis with hepatocellular carcinoma. Report of a case.

Authors:  R A Joske; B H Laurence; L R Matz
Journal:  Gastroenterology       Date:  1972-03       Impact factor: 22.682

3.  High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.

Authors:  R M Galbraith; M Smith; R M Mackenzie; D E Tee; D Doniach; R Williams
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

4.  Controlled trial of prednisone and azathioprine in active chronic hepatitis.

Authors:  I M Murray-Lyon; R B Stern; R Williams
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

5.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

Authors:  R D Soloway; W H Summerskill; A H Baggenstoss; M G Geall; G L Gitnićk; I R Elveback; L J Schoenfield
Journal:  Gastroenterology       Date:  1972-11       Impact factor: 22.682

6.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

7.  Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival.

Authors:  S P Mistilis; A P Skyring; C R Blackburn
Journal:  Australas Ann Med       Date:  1968-08

8.  Liver tumours and their management.

Authors:  R Williams; W M Melia
Journal:  Clin Radiol       Date:  1980-01       Impact factor: 2.350

9.  Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases.

Authors:  N Krasner; P J Johnson; B Portmann; G Watkinson; R N Macsween; R Williams
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

10.  Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.

Authors:  A P Kirk; S Jain; S Pocock; H C Thomas; S Sherlock
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

View more
  2 in total

1.  Hepatocellular carcinoma and lupoid hepatitis (an autopsy study).

Authors:  Y H Xu; R L Peters
Journal:  J Tongji Med Univ       Date:  1986

2.  Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis.

Authors:  R H Resnick; K Stone; D Antonioli
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.